JPH11302149A - Melanin production inhibitor and external preparation for skin containing the same - Google Patents

Melanin production inhibitor and external preparation for skin containing the same

Info

Publication number
JPH11302149A
JPH11302149A JP10121814A JP12181498A JPH11302149A JP H11302149 A JPH11302149 A JP H11302149A JP 10121814 A JP10121814 A JP 10121814A JP 12181498 A JP12181498 A JP 12181498A JP H11302149 A JPH11302149 A JP H11302149A
Authority
JP
Japan
Prior art keywords
melanin production
production inhibitor
weight
parts
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10121814A
Other languages
Japanese (ja)
Inventor
Akihiro Tada
明弘 多田
Tomoyoshi Kato
朋美 加藤
Takayuki Katagiri
崇行 片桐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP10121814A priority Critical patent/JPH11302149A/en
Publication of JPH11302149A publication Critical patent/JPH11302149A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a melanogenesis inhibitor by including a specific essence. SOLUTION: This external preparation for skin such as a skin lightening cosmetic or the like contains preferably 0.01-10 wt.% of a melanogenesis inhibitor composed of an essence of Illicium verum Hook fil.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、美白化粧料などの
皮膚外用剤に有益なメラニン産生抑制剤に関する。
TECHNICAL FIELD The present invention relates to a melanin production inhibitor useful for a skin external preparation such as a whitening cosmetic.

【0002】[0002]

【従来の技術】色白の美しい肌は、古来より全人が希望
してきたことであり、この様な肌を得るために数々の努
力が為されてきた。この中で、色の白さ、言い換えれば
色の黒さの原因が、メラノサイトで生成されるメラニン
であることが明らかにされた。このメラニンの量の多少
により、肌の色が黒くなったり白くなったりすることも
解明された。このメラニンの生合成には、チロシナーゼ
やチロシナーゼ関連蛋白質群と呼ばれる蛋白が関与して
いることも既に知られていることである。又、この様な
酵素等の働きを阻害し色白を具現化するための素材や化
粧料が開発され、かなりの程度は色を白くすることが可
能になってきた。しかしながら、色黒とメラニンの生合
成の関係についてこれらからでは説明しきれない因子が
残っており、又、色黒について、その種類によってメラ
ニンの生合成の関係因子が異なっていることもおぼろげ
ながら知られるようになってきた。しかしながら、従来
より、比較的効果が高いとされているメラニン産生抑制
剤であっても、その効果が発現しない人が存在すること
も既に良く知られていることである。この理由として
は、メラニン産生に関与する因子が多く、これの差違に
よって、メラニン産生抑制剤が効果を発揮したりしなか
ったりするものであると考えられている。この様な因子
とメラニン産生のメカニズムは解明されきっているとは
言えず、従って、種々の種類の新規のメラニン産生抑制
剤を探し出すことが望まれているのが現状と言わざるを
得ない。
2. Description of the Related Art Beautiful fair skin has been desired by all people since ancient times, and various efforts have been made to obtain such skin. In this, it was revealed that the cause of the whiteness of the color, in other words, the blackness of the color, was melanin generated in melanocytes. It was also clarified that depending on the amount of the melanin, the skin color became black or white. It is already known that proteins called tyrosinase and tyrosinase-related proteins are involved in the biosynthesis of melanin. In addition, materials and cosmetics for realizing fair skin by inhibiting the action of such enzymes and the like have been developed, and it has become possible to make the color white to a considerable extent. However, there remain factors that cannot be explained from the relationship between dark-black and melanin biosynthesis.Also, it is not surprising that the factors involved in melanin biosynthesis differ depending on the type of dark-black. It has become known. However, it has already been well known that even if a melanin production inhibitor is considered to have a relatively high effect, some people do not exhibit the effect. The reason for this is thought to be that there are many factors involved in melanin production, and that these differences may cause the melanin production inhibitor to exert no effect. It cannot be said that such factors and the mechanism of melanin production have been elucidated. Therefore, it has to be said that there is a need to find various kinds of novel melanin production inhibitors.

【0003】一方、ダイウイキョウ(大茴香)はシキミ
科(Illiciaceae)の植物であって、学名
I.verum Hook fil.と言うものが広く
知られており、別名スター・アニス、八角茴香又は八角
とも呼ばれ中華料理等の香辛料に使用されているが、こ
のエッセンスについて、その揮発成分がアルコール、取
り分けエタノールに由来する嗅覚刺激を緩和する作用を
有すること、及び熱水抽出物が保湿作用を有し、浴用剤
の成分として好適であることは既に知られているが、こ
のものがメラニン産生抑制作用を有すること、取り分け
果実部分の極性溶媒抽出物の非極性部分に含有される成
分にその作用が著しいことは全く知られていなかった。
又、美白化粧料にこの様なエッセンスを含有させること
も全く知られていなかった。
[0003] On the other hand, the fennel is a plant belonging to the family Lyricaceae and has the scientific name I. verum Hook file. It is widely known, and is also known as Star Anise, Octagon Fenka or Octagon, and is used in spices such as Chinese cuisine.The essence of this essence is derived from alcohol, especially ethanol, which is derived from alcohol. It is already known that it has an action to relieve irritation, and that the hot water extract has a moisturizing action and is suitable as a component of bath agents, but it has a melanin production inhibitory action. It was not known at all that the effect contained in the components contained in the non-polar part of the polar solvent extract of the fruit part was remarkable.
Further, it has not been known at all that the whitening cosmetic contains such an essence.

【0004】[0004]

【発明が解決しようとする課題】本発明は、かかる状況
下為されたものであり、新規のメラニン産生抑制剤を提
供することを課題とする。
DISCLOSURE OF THE INVENTION The present invention has been made under such circumstances, and an object of the present invention is to provide a novel melanin production inhibitor.

【0005】[0005]

【課題の解決手段】かかる状況に鑑みて、本発明者ら
は、新規のメラニン産生抑制剤を求めて鋭意研究を重ね
た結果、ダイウイキョウのエッセンスにこの様な特性を
見いだし、発明を完成させるに至った。以下、本発明に
ついて、発明の実施の形態を中心に詳細に説明を加え
る。
In view of such circumstances, the present inventors have conducted intensive studies in search of a novel melanin production inhibitor, and as a result, have found such characteristics in the essence of fennel, thereby completing the invention. Reached. Hereinafter, the present invention will be described in detail focusing on embodiments of the present invention.

【0006】(1)本発明のメラニン産生抑制剤 本発明のメラニン産生抑制剤は、ダイウイキョウのエッ
センスよりなる。ここで本発明で言うエッセンスとは、
植物体の全部或いは一部を、乾燥、細切、粉砕等加工し
た加工物、植物体の全部或いは一部又はそれらの加工物
を溶媒などで抽出した抽出物、抽出物の溶媒除去物、植
物体の全部或いは一部又はそれらの加工物を直接或いは
水蒸気の存在下蒸留した蒸留物、蒸留物や抽出物を、液
液抽出やカラムクロマトグラフィー等によって分画した
分画物等の総称を意味する。このうち抽出物は、水、メ
タノールやエタノールや1,3−ブタンジオール等のア
ルコール類、ジエチルエーテルやテトラヒドロフラン等
のエーテル類、クロロホルムや塩化メチレンなどのハロ
ゲン化炭化水素類、アセトンやメチルエチルケトン等の
ケトン類、酢酸エチルや蟻酸メチルなどのエステル類か
ら選ばれる1種乃至は2種以上が好ましく例示できる。
これらの内、アルコール類が安全性と溶解性の面から特
に好ましい。抽出は、植物体又はその加工物に対して1
〜10倍量の溶媒を加え、室温であれば数日、沸点付近
の温度であれば数時間浸漬すればよい。これらエッセン
スの内、本発明のメラニン産生抑制剤として、取り分け
好ましいものは、抽出物であり、中でもアルコール抽出
物が好ましく。アルコール抽出物より極性部分を液液抽
出などで除去したものが特に好ましい。この様な極性部
分の除去手段としての液液抽出は、例えば、メタノール
などで抽出した抽出物に溶媒を除去することなくノルマ
ルヘキサン等の炭化水素を加え、震盪し炭化水素層を取
り、溶媒を溜去する事やアルコール抽出物を一度濃縮し
酢酸エチルと水を加え溶解させ、震盪し酢酸エチル層を
取り、濃縮することなどが好ましく例示できる。又、か
かる抽出物を作成するための部位としては果実が特に好
ましい。これらが好ましい理由は、かかるエッセンスが
メラニン産生を抑制する作用に優れる成分を含有するか
らである。本発明の皮膚外用剤に於ける、当該メラニン
産生抑制剤の好ましい含有量は、0.01〜10重量%
であり、0.05〜5重量%が更に好ましい。
(1) Melanin production inhibitor of the present invention The melanin production inhibitor of the present invention comprises the essence of Fennel. Here, the essence referred to in the present invention is:
Processed product obtained by drying, shredding, pulverizing, etc. of the whole or part of the plant, extract of the whole or part of the plant or the processed product extracted with a solvent, solvent-extracted extract, plant A generic term for distillates obtained by distilling all or part of the body or their processed products directly or in the presence of steam, and fractionated products obtained by fractionating distillates and extracts by liquid-liquid extraction, column chromatography, etc. I do. Among them, extracts are water, alcohols such as methanol, ethanol and 1,3-butanediol, ethers such as diethyl ether and tetrahydrofuran, halogenated hydrocarbons such as chloroform and methylene chloride, and ketones such as acetone and methyl ethyl ketone. And one or more selected from esters such as ethyl acetate and methyl formate.
Of these, alcohols are particularly preferred from the viewpoint of safety and solubility. Extraction is performed on the plant or its processed product by 1
The solvent may be immersed for several days at room temperature or several hours at a temperature near the boiling point. Among these essences, particularly preferred as the melanin production inhibitor of the present invention are extracts, and among them, alcohol extracts are preferred. It is particularly preferable that the polar portion is removed from the alcohol extract by liquid-liquid extraction or the like. Liquid-liquid extraction as a means for removing such a polar portion is performed, for example, by adding a hydrocarbon such as normal hexane to the extract extracted with methanol or the like without removing the solvent, shaking to remove the hydrocarbon layer, and removing the solvent. Preferable examples include distilling off, concentrating the alcohol extract once, dissolving by adding ethyl acetate and water, shaking to remove the ethyl acetate layer, and concentrating. Fruit is particularly preferred as a site for preparing such an extract. These are preferable because such an essence contains a component having an excellent action of suppressing melanin production. The preferred content of the melanin production inhibitor in the skin external preparation of the present invention is 0.01 to 10% by weight.
And more preferably 0.05 to 5% by weight.

【0007】(2)本発明の皮膚外用剤 本発明の皮膚外用剤は上記メラニン産生抑制剤を含有す
ることを特徴とする。本発明の皮膚外用剤としては、例
えば、皮膚外用医薬組成物や化粧料が好ましく例示でき
るが、この内化粧料が好ましく、中でも美白用の化粧料
が特に好ましい。これは、本発明の必須成分のメラニン
産生抑制剤の効果をより良く具現できるからである。本
発明の化粧料に於いては、上記必須成分であるメラニン
産生抑制剤以外に通常化粧料や皮膚外用剤で使用される
任意成分を含有することが出来る。かかる任意成分とし
ては、例えば、ワセリンやマイクロクリスタリンワック
ス等のような炭化水素類、ホホバ油やゲイロウ等のエス
テル類、牛脂、オリーブ油等のトリグリセライド類、セ
タノール、オレイルアルコール等の高級アルコール類、
ステアリン酸、オレイン酸等の脂肪酸、グリセリンや
1,3−ブタンジオール等の多価アルコール類、非イオ
ン界面活性剤、アニオン界面活性剤、カチオン界面活性
剤、両性界面活性剤、エタノール、カーボポール等の増
粘剤、防腐剤、紫外線吸収剤、抗酸化剤、色素、粉体類
等が好ましく例示できる。中でも、ビタミンCとその誘
導体、アルブチンなどのハイドロキノンの配糖体、レゾ
ルシノールとその誘導体等の美白成分を含有させること
もできる。本発明の皮膚外用剤はこれらの成分を常法に
従って処理することにより、製造することが出来る。本
発明の皮膚外用剤は、液体製剤、乳化クリーム製剤、乳
液製剤、ムース状製剤、軟膏製剤等何れの剤形形態をと
ることも可能である。本発明に使用されるメラニン産生
抑制剤の基源植物が古来より広く食品で使用されてきた
ものであることから、本発明のメラニン産生抑制剤や皮
膚外用剤が優れた安全性を有することは言うまでもな
い。
(2) External preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing the above-mentioned melanin production inhibitor. As the external preparation for skin of the present invention, for example, a pharmaceutical composition for external use on skin and cosmetics can be preferably exemplified. Among them, internal cosmetics are preferable, and cosmetics for whitening are particularly preferable. This is because the effect of the melanin production inhibitor, which is an essential component of the present invention, can be realized better. The cosmetic of the present invention can contain optional components usually used in cosmetics and external preparations for the skin, in addition to the above-mentioned melanin production inhibitor as an essential component. Such optional components include, for example, hydrocarbons such as petrolatum and microcrystalline wax, esters such as jojoba oil and gay wax, tallow, triglycerides such as olive oil, cetanol, and higher alcohols such as oleyl alcohol.
Fatty acids such as stearic acid and oleic acid, polyhydric alcohols such as glycerin and 1,3-butanediol, nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, ethanol, carbopol, etc. Preferred examples include thickeners, preservatives, ultraviolet absorbers, antioxidants, pigments, and powders. Above all, whitening components such as vitamin C and its derivatives, hydroquinone glycosides such as arbutin, and resorcinol and its derivatives can be contained. The external preparation for skin of the present invention can be produced by treating these components according to a conventional method. The external preparation for skin of the present invention can take any dosage form such as a liquid preparation, an emulsion cream preparation, an emulsion preparation, a mousse preparation, an ointment preparation and the like. Since the base plant of the melanin production inhibitor used in the present invention has been widely used in foods since ancient times, the melanin production inhibitor and the skin external preparation of the present invention have excellent safety. Needless to say.

【0008】[0008]

【実施例】以下に実施例を挙げて、本発明について更に
詳細に説明を加えるが、本発明がかかる実施例にのみ限
定を受けないことは言うまでもない。
The present invention will be described in more detail with reference to the following examples, but it goes without saying that the present invention is not limited only to these examples.

【0009】<実施例1> 製造例 ダイウイキョウ(I.verum Hook fi
l.)の果実部分500gを5lのメタノールに室温で
7日間浸漬し、濾過して不溶性部分を取り除いた後、濃
縮しエッセンス1(メラニン産生抑制剤1)を得た。こ
のものに塩化メチレンと水とを1lづつ加え、震盪し塩
化メチレン層を取り、濃縮しエッセンス2(メラニン産
生抑制剤2)とした。
<Example 1> Production Example Daikyo (I. verum Hook fi)
l. ) Was immersed in 5 l of methanol at room temperature for 7 days, filtered to remove insoluble portions, and concentrated to obtain essence 1 (melanin production inhibitor 1). One liter of methylene chloride and water were added thereto, and the mixture was shaken to remove the methylene chloride layer and concentrated to obtain essence 2 (melanin production inhibitor 2).

【0010】<実施例2> 製造例 ダイウイキョウの果実部分500gを5lのメタノール
に室温で7日間浸漬し、濾過して不溶性部分を取り除い
た後、ノルマルヘキサン5lを加え、震盪しノルマルヘ
キサン層を取り、濃縮しエッセンス3(メラニン産生抑
制剤3)とした。
<Example 2> Preparation Example 500 g of the fruit portion of the Fennel is immersed in 5 l of methanol at room temperature for 7 days, and the insoluble portion is removed by filtration. The extract was concentrated and used as essence 3 (melanin production inhibitor 3).

【0011】<実施例3> メラニン産生抑制作用 上記エッセンス1〜3について、メラニン産生抑制作用
をマウスメラノーマB−16 F1細胞を用いて、メラ
ニン産生抑制作用を調べた。即ち、プラスチック培養フ
ラスコ(25cm2)内の10%FBS加RPMI−1
640培地に2×105個のマウスメラノーマB−16
F1細胞を播種し、5%炭酸ガス加気流中37℃で培
養した。播種24時間後、最終濃度1×10ー3(W/
V)%となるように、上記メラニン産生抑制剤をDMS
Oに溶解させて加え、更に2日間培養した。この際、D
MSOは最終濃度で0.2%を越えないように注意し
た。培養終了後、培地を除き、燐酸緩衝生理食塩水液で
洗浄後、トリプシン処理し細胞を剥離させ、遠心分離に
より細胞を回収し、細胞数より細胞毒性を、細胞の色よ
りメラニン産生抑制作用を判定した。判定基準は細胞毒
性が、++:検体無添加(対照)に比し著しく少ない、
+:対照に比し明らかに少ない、±:対照に比しやや少
ない、−:対照に比し同程度であり、メラニン産生抑制
作用は、++:対照に比し著しく白い、+:対照に比し
明らかに白い、±:対照に比しやや白い、−:対照同程
度に黒いであった。結果を表1に示す。これより、本発
明のメラニン産生抑制剤は細胞毒性が低いにもかかわら
ずメラニン産生抑制作用に優れることがわかる。
<Example 3> Melanin production inhibitory action The above essences 1 to 3 were examined for melanin production inhibitory action using mouse melanoma B-16 F1 cells. That is, RPMI-1 with 10% FBS in a plastic culture flask (25 cm 2 )
2 × 10 5 mouse melanoma B-16 in 640 medium
F1 cells were inoculated and cultured at 37 ° C. in a stream of 5% carbon dioxide gas. 24 hours after sowing, the final concentration was 1 × 10−3 (W /
V) The above melanin production inhibitor is DMS
After dissolving in O, the cells were further cultured for 2 days. At this time, D
Care was taken that the MSO did not exceed 0.2% at the final concentration. After cultivation, remove the medium, wash with phosphate-buffered saline, and trypsinize to detach the cells.Collect the cells by centrifugation. Judged. The criterion is that the cytotoxicity is significantly less than ++: no sample added (control),
+: Apparently lower than control, ±: slightly lower than control, −: comparable to control, melanin production inhibitory effect ++: significantly whiter than control, +: higher than control It was apparently white, ±: slightly white compared to the control, −: black as much as the control. Table 1 shows the results. This indicates that the melanin production inhibitor of the present invention is excellent in melanin production inhibitory action despite low cytotoxicity.

【0012】[0012]

【表1】 [Table 1]

【0013】<実施例4>以下に示す処方に従って、本
発明の化粧料を作成した。即ち、処方成分を室温で攪拌
溶解し、本発明の化粧料である化粧水を得た。 メラニン産生抑制剤1 1 重量部 ポリオキシエチレン(60)硬化ヒマシ油 0.5重量部 エタノール 10 重量部 グリセリン 5 重量部 水 83.5重量部
Example 4 A cosmetic of the present invention was prepared according to the following formulation. That is, the ingredients were stirred and dissolved at room temperature to obtain a lotion as the cosmetic of the present invention. Melanin production inhibitor 1 1 part by weight Polyoxyethylene (60) hydrogenated castor oil 0.5 part by weight Ethanol 10 parts by weight Glycerin 5 parts by weight Water 83.5 parts by weight

【0014】<実施例5>以下に示す処方に従って、本
発明の化粧料を作成した。即ち、処方成分を室温で攪拌
溶解し、本発明の化粧料である化粧水を得た。 メラニン産生抑制剤2 0.1重量部 ポリオキシエチレン(60)硬化ヒマシ油 0.5重量部 エタノール 10 重量部 グリセリン 5 重量部 水 84.4重量部
Example 5 A cosmetic of the present invention was prepared according to the following formulation. That is, the ingredients were stirred and dissolved at room temperature to obtain a lotion as the cosmetic of the present invention. Melanin production inhibitor 2 0.1 parts by weight Polyoxyethylene (60) hydrogenated castor oil 0.5 parts by weight Ethanol 10 parts by weight Glycerin 5 parts by weight Water 84.4 parts by weight

【0015】<実施例6>以下に示す処方に従って、本
発明のクリームを作成した。即ち、イの成分を良く混練
りした後、80℃に加熱し、ロ、ハを予め80℃に予熱
しておき、イにロを加え希釈し、これにハを徐々に加え
乳化し、攪拌冷却しクリームを得た。 イ トリグリセリンジイソステアレート 5 重量部 マルチトール70%水溶液 5 重量部 グリセリン 3 重量部 1,3−ブタンジオール 5 重量部 メラニン産生抑制剤2 0.7重量部 メチルパラベン 0.2重量部 ブチルパラベン 0.1重量部 ロ 流動パラフィン 15 重量部 マイクロクリスタリンワックス 3 重量部 ネオペンチルグリコールジイソオクタネート 5 重量部 カルナウバワックス 2 重量部 ハ 水 56 重量部
Example 6 A cream according to the present invention was prepared according to the following formulation. That is, after well kneading the components of (a), the mixture is heated to 80 ° C., and (b) and (c) are preheated to 80 ° C., (b) is added and diluted, (c) is gradually added, emulsified, and stirred. Upon cooling, a cream was obtained. I Triglycerin diisostearate 5 parts by weight Maltitol 70% aqueous solution 5 parts by weight Glycerin 3 parts by weight 1,3-butanediol 5 parts by weight Melanin production inhibitor 2 0.7 parts by weight Methyl paraben 0.2 parts by weight Butyl paraben 0 Liquid paraffin 15 parts by weight Microcrystalline wax 3 parts by weight Neopentyl glycol diisooctaneate 5 parts by weight Carnauba wax 2 parts by weight C Water 56 parts by weight

【0016】<実施例7>以下に示す処方に従って、本
発明のクリームを作成した。即ち、イの成分を良く混練
りした後、80℃に加熱し、ロ、ハを予め80℃に予熱
しておき、イにロを加え希釈し、これにハを徐々に加え
乳化し、攪拌冷却しクリームを得た。 イ トリグリセリンジイソステアレート 5 重量部 マルチトール70%水溶液 5 重量部 グリセリン 3 重量部 1,3−ブタンジオール 5 重量部 メラニン産生抑制剤3 0.7重量部 メチルパラベン 0.2重量部 ブチルパラベン 0.1重量部 ロ 流動パラフィン 15 重量部 マイクロクリスタリンワックス 3 重量部 ネオペンチルグリコールジイソオクタネート 5 重量部 カルナウバワックス 2 重量部 ハ 水 56 重量部
Example 7 A cream according to the present invention was prepared according to the following formulation. That is, after well kneading the components of (a), the mixture is heated to 80 ° C., and (b) and (c) are preheated to 80 ° C., (b) is added and diluted, (c) is gradually added, emulsified, and stirred. Upon cooling, a cream was obtained. I Triglycerin diisostearate 5 parts by weight Maltitol 70% aqueous solution 5 parts by weight Glycerin 3 parts by weight 1,3-butanediol 5 parts by weight Melanin production inhibitor 3 0.7 parts by weight Methyl paraben 0.2 parts by weight Butyl paraben 0 Liquid paraffin 15 parts by weight Microcrystalline wax 3 parts by weight Neopentyl glycol diisooctaneate 5 parts by weight Carnauba wax 2 parts by weight C Water 56 parts by weight

【0017】<実施例8>上記実施例5の化粧水を用い
て、実使用試験を行い美白効果を確かめた。即ち、色黒
に悩むパネラー1群10名、4群計40名を用い、実施
例5の化粧水、実施例5の化粧水のメラニン産生抑制剤
2をビタミンCナトリウム塩に置換した比較例1、実施
例5の化粧水のメラニン産生抑制剤2をアルブチンに置
換した比較例2、実施例5の化粧水のメラニン産生抑制
剤2を水に置換した対照例の4群で、朝晩1日2回、2
カ月連続使用してもらい、色黒の改善の印象を++:す
ばらしい改善、+:明らかな改善、±:やや改善、−:
改善せずのランクに分けてアンケートで答えてもらっ
た。結果を表2に出現例数として示す。これより、本発
明の化粧料は美白作用に優れることがわかる。
Example 8 Using the lotion of Example 5, an actual use test was performed to confirm the whitening effect. That is, Comparative Example 1 in which the melanin production inhibitor 2 of Example 5 and the melanin production inhibitor 2 of Example 5 were replaced with vitamin C sodium salt using 10 panelists in a group suffering from black and white and 4 groups in total of 40 persons. The four groups of Comparative Example 2 in which the melanin production inhibitor 2 of Example 5 was replaced with arbutin, and the control example in which the melanin production inhibitor 2 of Example 5 was replaced with water were used in the morning and evening 2 days a day. Times, 2
Having been used for months in a row, the impression of improvement in color and black was ++: excellent improvement, +: obvious improvement, ±: slightly improvement,-:
We asked them to answer the questionnaire according to their rank without improvement. The results are shown in Table 2 as the number of occurrences. This indicates that the cosmetic of the present invention has an excellent whitening effect.

【0018】[0018]

【表2】 [Table 2]

【0019】[0019]

【発明の効果】本発明によれば、新規のメラニン産生抑
制剤を提供することができる。
According to the present invention, a novel melanin production inhibitor can be provided.

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 ダイウイキョウ(大茴香)のエッセンス
からなる、メラニン産生抑制剤。
1. A melanin production inhibitor comprising the essence of Daikyo (Daen Feng).
【請求項2】 エッセンスが果実部分の極性溶媒抽出物
である、請求項1に記載のメラニン産生抑制剤。
2. The melanin production inhibitor according to claim 1, wherein the essence is a polar solvent extract of a fruit portion.
【請求項3】 エッセンスが果実部分の極性溶媒抽出物
の非極性部分であることを特徴とする、請求項1又は2
に記載のメラニン産生抑制剤。
3. The method according to claim 1, wherein the essence is a non-polar part of a polar solvent extract of the fruit part.
5. The melanin production inhibitor according to the above.
【請求項4】 請求項1〜3の何れか一項に記載のメラ
ニン産生抑制剤を含有する、皮膚外用剤。
4. An external preparation for skin, comprising the melanin production inhibitor according to any one of claims 1 to 3.
【請求項5】 美白化粧料であることを特徴とする、請
求項4に記載の皮膚外用剤。
5. The external preparation for skin according to claim 4, which is a whitening cosmetic.
【請求項6】 ダイウイキョウの果実部分の極性溶媒抽
出物の非極性部分を含有する、化粧料。
6. A cosmetic composition comprising a non-polar portion of a polar solvent extract of a fruit portion of a fennel.
【請求項7】 美白作用を有することを特徴とする、請
求項6に記載の化粧料。
7. The cosmetic according to claim 6, which has a whitening effect.
JP10121814A 1998-04-15 1998-04-15 Melanin production inhibitor and external preparation for skin containing the same Pending JPH11302149A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10121814A JPH11302149A (en) 1998-04-15 1998-04-15 Melanin production inhibitor and external preparation for skin containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10121814A JPH11302149A (en) 1998-04-15 1998-04-15 Melanin production inhibitor and external preparation for skin containing the same

Publications (1)

Publication Number Publication Date
JPH11302149A true JPH11302149A (en) 1999-11-02

Family

ID=14820599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10121814A Pending JPH11302149A (en) 1998-04-15 1998-04-15 Melanin production inhibitor and external preparation for skin containing the same

Country Status (1)

Country Link
JP (1) JPH11302149A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009215266A (en) * 2008-03-12 2009-09-24 Kose Corp Skin lightening agent containing shikimic acid as beneficial ingredient
JP2014015480A (en) * 2006-04-25 2014-01-30 Bourges Cedric Use of saffron and/or safranal and/or picrocrocin and/or crocin and/or derivatives thereof for treatment of obesity
US8962695B2 (en) 2009-06-22 2015-02-24 J-Oil Mills, Inc. Hyaluronic acid production promoter and melanin production inhibitor
CN113662888A (en) * 2020-05-15 2021-11-19 弘光科技大学 Whitening essential oil composition and application thereof
TWI748424B (en) * 2020-04-27 2021-12-01 弘光科技大學 Whitening essential oil composition and its use
KR20220015359A (en) * 2020-07-30 2022-02-08 김유근 A cosmetic composition for skin whitening comprising Illicium Verum Fruit extracts, fractions thereof or compounds isolated therefrom as an active ingredient

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014015480A (en) * 2006-04-25 2014-01-30 Bourges Cedric Use of saffron and/or safranal and/or picrocrocin and/or crocin and/or derivatives thereof for treatment of obesity
US9833489B2 (en) 2006-04-25 2017-12-05 Cedric Bourges Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity
JP2009215266A (en) * 2008-03-12 2009-09-24 Kose Corp Skin lightening agent containing shikimic acid as beneficial ingredient
US8962695B2 (en) 2009-06-22 2015-02-24 J-Oil Mills, Inc. Hyaluronic acid production promoter and melanin production inhibitor
TWI748424B (en) * 2020-04-27 2021-12-01 弘光科技大學 Whitening essential oil composition and its use
CN113662888A (en) * 2020-05-15 2021-11-19 弘光科技大学 Whitening essential oil composition and application thereof
KR20220015359A (en) * 2020-07-30 2022-02-08 김유근 A cosmetic composition for skin whitening comprising Illicium Verum Fruit extracts, fractions thereof or compounds isolated therefrom as an active ingredient

Similar Documents

Publication Publication Date Title
JP2003300860A (en) Skin care preparation
JP2005082522A (en) Bleaching cosmetic
JP2012001467A (en) Skin external preparation
JP2002370922A (en) Cosmetic containing japanese plum extract
JPH11302149A (en) Melanin production inhibitor and external preparation for skin containing the same
JP2004345959A (en) Melanogenesis promoter and melanogenesis-promoting composition
JPH10279428A (en) Cosmetic
JP3933535B2 (en) Cell activator
JP2000143491A (en) Cosmetic for caring aging
JPH10120546A (en) Skin whitening preparation for external use
KR102320918B1 (en) Whitening cosmetic composition comprising Sargassum serratifolium and poloxamer and use thereof
JPH07145033A (en) Cosmetic for prevention of dermal aging
JP4076477B2 (en) Skin preparation
JPH1036216A (en) Skin cosmetic
JP3217741B2 (en) Whitening agent
JP6242575B2 (en) Dendritic elongation inhibitor
JP2018002703A (en) Psoriasin production promoter
JPH1180016A (en) Preparation for external use for skin for prevention of aging
JP2896814B2 (en) Cosmetics
JP2811479B2 (en) Hair restoration
JP3608776B2 (en) Topical skin preparation
JP4959103B2 (en) Whitening agent and external preparation for skin
JP4473439B2 (en) Whitening agent
JP4959104B2 (en) Whitening agent and external preparation for skin
JP2003267851A (en) Skin care preparation